VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announces the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based excipients, to its growing portfolio. This acquisition serves as the second investment under VION Biosciences LLC (“VION Biosciences”), Iron Path Capital’s roll-up platform in the life science sector led by life science industry veteran, Mark Thornton.
Read the full article: VION Biosciences Acquires Industry Leader in Specialty Lipids and Lipid Nanoparticles, Echelon Biosciences //
Source: https://www.businesswire.com/news/home/20240822392674/en/VION-Biosciences-Acquires-Industry-Leader-in-Specialty-Lipids-and-Lipid-Nanoparticles-Echelon-Biosciences